DNA Capital: A multi-stage healthcare investment partnership.
Location
São Paulo, BR
Founded
2013
DNA Capital is a multi-stage investment partnership focused on the healthcare and healthtech sectors. They invest across all stages, from early-stage startups with potential to shape the future of healthcare to late-stage companies spanning the breadth of the industry. Their portfolio companies collectively treat millions of patients annually.
Notable investments include Alto Pharmacy, Arterys, Clover Health, Nice Healthcare, Reema Health, and Spotlight Therapeutics. DNA Capital partners with exceptional founders and management teams, empowering them to build leading healthcare businesses. They offer expertise and support to help portfolio companies achieve their potential in the rapidly evolving healthcare landscape.
DNA Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies8
Current Portfolio Count6
Total Portfolio Exits2
Top Investment Stages
Series A2 (28.6%)
Series B2 (28.6%)
Seed1 (14.3%)
Series C1 (14.3%)
Series D1 (14.3%)
Stage Mix
Series A 29%Series B 29%Seed 14%Series C 14%Series D 14%
Concentration shown as share of disclosed investments by stage.
